MOA for Combination Treatment | MYRBETRIQ® (mirabegron)
Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladder - ScienceDirect
Attachment 1. Product Information for mirabegron
Mirabegron - Goulooze - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library
Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis | PNAS
PDF) The efficacy of mirabegron in the treatment of urgency and the potential utility of combination therapy
Sites of action and mechanisms of therapeutic agents used for the... | Download Scientific Diagram
Bladder drug mirabegron exacerbates atherosclerosis through activation of brown fat-mediated lipolysis | PNAS
MYRBETRIQ™ (mirabegron) - Renal and Urology News
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II) - European Urology
Roivant Sciences
GP Educational Evening 12th February - ppt video online download
Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH) - ScienceDirect
Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials - ScienceDirect
PDF) safety and efficacy of mirabegron compared to propiverine for managing symptoms in benign prostatic hyperplasia
The β3‐adrenoceptor agonist mirabegron increases human atrial force through β1‐adrenoceptors: an indirect mechanism? - Mo - 2017 - British Journal of Pharmacology - Wiley Online Library
MOA for Combination Treatment | MYRBETRIQ® (mirabegron)
